CARDIAC SURGERY INSTRUMENT MARKET ANALYSIS

Cardiac Surgery Instrument Market, By Product Type (Surgical Instruments, Monitoring & Diagnostic Instruments, Cardiopulmonary Bypass Equipment, Sutures & Staples, Catheters & Guidewires)By Application (Coronary Artery Bypass Grafting (CABG), Heart Valve Repair/Replacement, Arrhythmia Treatment, Aneurysm Repair, Congenital Heart Defect Repair, Transplants), By End User (Hospitals, Ambulatory Surgical Centers, Research Institutes), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Recent Developments

New product approvals

On October 23, 2023, Medtronic plc., a global leader in healthcare technology, has received U.S. Food and Drug Administration (FDA) approval for the Aurora EV-ICD MRI SureScan (Extravascular Implantable Cardioverter-Defibrillator) and Epsila EV MRI SureScan defibrillation lead to treat dangerously fast heart rhythms that can lead to sudden cardiac arrest (SCA).
On August 1, 2023, Teleflex Incorporated, a global provider of medical technologies, has announced the U.S Food and Drug Administration (FDA) has cleared the QuikClot Control Hemostatic Device to include mild and moderate bleeding in cardiac surgical procedures and bone surface bleeding following a sternotomy. This allows clinicians to use the QuikClot Control Device to control all bleeding in cardiac surgical procedures.
On September 12, 2023, CorVista Health, Inc., a digital health company dedicated to improving cardiovascular disease diagnosis, has announced the U.S. FDA clearance of the CorVista System with CAD Add-On to evaluate the presence of significant coronary artery disease as an aid in diagnosis.

Collaboration

On January 25, 2023, Terumo Corporation, is a global leader in medical technology and Siemens Healthineers, India, a company which provides healthcare solutions and services has collaboration for strengthening cardiac care in India through physician training and development, access to advanced medical technologies, and improved penetration of Tier 2 and 3 cities. The collaboration will flag off its efforts with a customized training program for Cathlab professionals, being developed in partnership with an eminent academic institute in India.
On October 13, 2023, GE Healthcare, a global medical technology company, and intravascular ultrasound (IVUS) market leader Boston Scientific Corporation has announced a collaboration that enables improved intravascular ultrasound (IVUS) workflow between the GE Healthcare Innova Cardiovascular X-ray System and the Boston Scientific iLab Ultrasound Imaging System.